Laffer Tengler Investments Embecta Corp. Transaction History

Laffer Tengler Investments

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$12.87 - $19.09 $244 - $362	-19 Reduced 19.19%	80 $1.51 Million
Q3 2023 Nov 14, 2023	BUY	$15.0 - $22.17 $285 - $421	19 Added 23.75%	99 $1.49 Million
Q2 2023 Aug 14, 2023	BUY	$21.6 - $30.69 $1,728 - $2,455	80 New	80 $1.73 Million
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $1,982 - $2,668	80 New	80 $2.03 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

Stay updated on Laffer Tengler Investments with notifications on news.